Orally Inhaled & Nasal Drug Delivery – An Evolving Pipeline Creating New Opportunities
Summary: Catalent’s Carla Vozone discusses the significant trends in the Orally Inhaled & Nasal Drug Delivery (OINDP) segment including larger molecules and novel indications. She also discusses changes within CDMOs and various challenges facing the industry. Download the e-book to learn more.